A potential contribution of chemotherapy to the activation of CSCs was shown by the enrichment of CD44 and ALDH1A3 in the tumoroids derived from gastric tumor tissues from Apc1638N mice, which reduced their size upon FOLFOX treatment. The gene discussed is CD44; the disease is gastric neoplasm.